LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells. VIVEbiotech, a company specialized in the production of lentiviral vectors for their use in gene therapy, has received notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office. LENTISOMA...Read more
Four aspects of the Invest in the Basque Country strategy of the SPRI Group and the Basque Government have received awards Alex Arriola, SPRI Group General Manager, today collected the award given in Cannes by the fDi Intelligence Magazine, part of the Financial Times Group, recognising once again that the Basque Country is an attractive territory for foreign investment. On this occasion, four...Read more
With the new investment fund, the managers plan to build two new plants in San Sebastian Columbus Venture Partners already has its second fund ready to invest in companies related to health sciences. It is in the registration phase at the National Securities Market Commission (CNMV) and will be operational shortly. The expected volume is 70 million euros, reports Expansión. According to...Read more
News 4 June, 2018 DigitalisationLatest innovations and first-hand business models
This analysis, driven by the B·Womenin Industry initiative in the Basque Country and replicated in Europe, shows that the most competitive companies also have the most level playing field in terms of gender. These companies - with gender balanced teams and workplaces that value female talent - are not only increasing revenue and stimulating innovation, but they also foster more stable and sustainable business decisions. Thanks to inclusive recruitment processes, equality plans and workplace...Read more
